Document Detail


Is left ventricular dysfunction reversed after treatment of active acromegaly?
MedLine Citation:
PMID:  20963505     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
It has been suggested that control of GH and IGF excess can arrest the progression of cardiovascular abnormalities and normalize cardiac performance. The aim of the present study was to investigate the reversibility of acromegalic cardiomyopathy in patients with active and inactive disease and to evaluate the effect of the inactivity of the disease on left ventricular (LV) diastolic dysfunction, irrespective of the applied treatment. The patient population consisted of 55 patients who were studied in the active and/or inactive phase. A complete M-mode, two-dimensional and color-flow Doppler echocardiographic examination was performed. LV mass index and posterior wall index were significantly lower in patients with inactive acromegaly compared to those with active disease (P < 0.03 respectively). Diastolic dysfunction was improved in patients with inactive compared to those with active disease (E/A ratio P < 0.009). IGF was positively correlated with LV mass index (r = 0.28, P < 0.02). Multivariate linear regression analysis showed that in active patients the E/A ratio was independently related to age (β = -0.674, P < 0.001) and GH (β = 0.282, P < 0.03), whereas in inactive patients none of the parameters were related significantly with the E/A ratio. In a subgroup of 15 patients who were studied in both the active and inactive phase of the disease, the reduction in GH levels was correlated positively with the reduction in LV mass index (r = 0.89, P < 0.0001) and negatively with the improvement in E/A ratio (r = -0.74, P < 0.001). In conclusion, the results of the present study indicate an improvement of left ventricular diastolic function and a significant improvement of cardiac hypertrophy in patients with inactive acromegaly and normal systolic cardiac function compared to those with active disease.
Authors:
Savvas T H Toumanidis; Maria Eleftheria Evangelopoulos; Ioannis Ilias; Constantinos Pamboucas; Chrysanthi Trikka; Maria Alevizaki
Related Documents :
12612985 - Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients.
501925 - Echocardiographic evaluation of right ventricular anterior wall motion in the wolff-par...
3180895 - Cardiac effects of common viral illnesses.
11153745 - Congenital heart block: development of late-onset cardiomyopathy, a previously underapp...
22073845 - Does cinacalcet hcl, an oral calcimimetic agent for the treatment of secondary hyperpar...
8247565 - Neurotologic manifestations of chiari 1 malformation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pituitary     Volume:  14     ISSN:  1573-7403     ISO Abbreviation:  Pituitary     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9814578     Medline TA:  Pituitary     Country:  United States    
Other Details:
Languages:  eng     Pagination:  75-9     Citation Subset:  IM    
Affiliation:
Department of Clinical Therapeutics, Medical School, University of Athens, "Alexandra" Hospital, 80 Vas. Sophias Ave.-Lourou Str., 115 28, Athens, Greece, stouman@otenet.gr.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Development and initial validation of Perceived Rehabilitation Needs Questionnaire for people with s...
Next Document:  [Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hos...